数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

股本结构

单位:万股
公告日期 2022-11-09 2022-11-09 2022-08-08 2022-08-08 2022-04-27 2022-05-05
证券总股本 14495.53 14480.44 14448.02 14447.27 14387.91 14386.92
普通股本 14495.53 14480.44 14448.02 14447.27 14387.91 14386.92
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2022-11-04 2022-09-30 2022-07-29 2022-06-30 2022-04-11 2022-03-31
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2022-11-09 14495.53 未披露 定期报告 2022-11-04
2022-11-09 14480.44 未披露
更多>>
From June 30, 2022 to September 30, 2022 Issuance of common stock from vesting of restricted stock units
2022-09-30
2022-08-08 14448.02 未披露 定期报告 2022-07-29
2022-08-08 14447.27 未披露
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock from vesting of restricted stock units Issuance of common stock under employee stock purchase plan
2022-06-30
2022-04-27 14387.91 未披露 定期报告 2022-04-11
2022-05-05 14386.92 未披露
更多>>
From January 1, 2022 to March 31, 2022 Issuance of common stock, net of issuance costs Issuance of common stock from vesting of restricted stock units
2022-03-31
2022-02-24 14224.47 未披露 定期报告 2022-02-22
2022-02-24 12910.95 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock, net of issuance costs Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units
2021-12-31
2021-11-03 12997.91 未披露 定期报告 2021-10-29
2021-11-03 12797.30 未披露
更多>>
from June 30, 2021 to September 30, 2021 Issuance of common stock from vesting of restricted stock units Issuance of common stock, net of issuance costs
2021-09-30
2021-08-04 11840.98 未披露 定期报告 2021-07-30
2021-08-04 11840.40 未披露
更多>>
From March 31, 2021 to June 30, 2021 Exercise of stock options Issuance of common stock from vesting of restricted stock units Issuance of common stock under employee stock purchase plan Issuance of common stock, net of issuance costs
2021-06-30
2021-04-28 10456.50 未披露 定期报告 2021-04-12
2021-05-05 10455.80 未披露
更多>>
from January 1, 2021 to March 31, 2021 Exercise of stock options Issuance of common stock from vesting of restricted stock units
2021-03-31
2021-02-25 10452.97 未披露 定期报告 2021-02-12
2021-02-25 10369.91 未披露
更多>>
From December 31, 2019 to December 31, 2020 Issuance of common stock, net of issuance costs Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units Convertible senior notes conversion
2020-12-31
2020-11-05 8831.90 未披露 定期报告 2020-10-30
2020-11-05 8830.91 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issuance of common stock from vesting of restricted stock units
2020-09-30
2020-08-07 8820.30 未披露 定期报告 2020-07-31
2020-08-07 8819.67 未披露
更多>>
From March 31, 2020 to June 30, 2020 Exercise of stock options Issuance of common stock from vesting of restricted stock units Issuance of common stock under employee stock purchase plan Issuance of common stock, net of issuance costs Convertible senior notes conversion
2020-06-30
2020-05-21 8791.83 未披露
更多>>
Clovis Oncology, Inc. (NASDAQ:CLVS) announced today the pricing of 11,090,000 shares of its common stock in an underwritten public offering at a price to the public of $8.05 per share, before underwriting discounts and commissions. Clovis Oncology also granted to the underwriters a 30-day option to purchase up to an additional 1,663,500 shares of its common stock on the same terms and conditions. The offering is expected to close on May 21, 2020.
2020-05-21
2020-05-06 7690.09 未披露 定期报告 2020-05-05
2020-04-24 7350.52 未披露 定期报告 2020-04-06
2020-05-06 7349.66 未披露
更多>>
From January 1, 2020 to March 31, 2020 Exercise of stock options Issuance of common stock from vesting of restricted stock units Convertible senior notes conversion
2020-03-31
2020-02-26 7344.86 未披露 定期报告 2020-02-15
2020-02-26 5495.63 未披露
更多>>
From December 31, 2018 to December 31, 2019 Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units Legal settlement
2019-12-31
2019-11-07 5481.52 未披露 定期报告 2019-11-01
2019-11-07 5480.55 未披露
更多>>
From June 30, 2019 to September 30, 2019 Litigation settlement Exercise of stock options Issuance of common stock from vesting of restricted stock units
2019-09-30
2019-08-02 5465.65 未披露 定期报告 2019-07-26
2019-08-02 5317.05 未披露
更多>>
from March 31, 2019 to June 30,2019 Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units
2019-06-30
2019-05-07 5300.48 未披露 定期报告 2019-05-03
2019-04-26 5300.00 未披露 定期报告 2019-04-08
2019-05-07 5299.41 未披露
更多>>
from January 1, 2019 to March 31, 2019 Exercise of stock options Issuance of common stock from vesting of restricted stock units, net of shares withheld for taxes
2019-03-31
2019-02-28 5286.86 未披露 定期报告 2019-02-22
2019-02-28 5279.75 未披露
更多>>
from December 31, 2017 to December 31, 2018 Issuance of common stock, net of issuance costs Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units, net of shares withheld for taxes
2018-12-31
2018-11-01 5271.18 未披露 定期报告 2018-10-26
2018-11-01 5270.88 未披露 定期报告 2018-09-30
2018-08-02 5264.96 未披露 定期报告 2018-07-27
2018-08-02 5263.74 未披露 定期报告 2018-06-30
2018-05-09 5254.90 未披露 定期报告 2018-05-04
2018-04-27 5070.51 未披露 定期报告 2018-04-09
2018-05-09 5069.75 未披露 定期报告 2018-03-31
2018-02-27 5057.32 未披露 定期报告 2018-02-21
2018-02-27 5056.51 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issuance of common stock, net of issuance costs Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units, net of shares withheld for taxes Legal settlement
2017-12-31
2017-11-02 4901.49 未披露 定期报告 2017-10-27
2017-11-02 4900.25 未披露 定期报告 2017-09-30
2017-08-03 4887.94 未披露 定期报告 2017-07-28
2017-08-03 4884.31 未披露 定期报告 2017-06-30
2017-05-04 4477.26 未披露 定期报告 2017-04-28
2017-04-26 4477.13 未披露 定期报告 2017-04-10
2017-05-04 4476.98 未披露 定期报告 2017-03-31
2017-02-23 4462.65 未披露 定期报告 2017-02-16
2017-02-23 3872.41 未披露
更多>>
from December 31, 2015 to December 31, 2016 Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units, net of shares withheld for taxes
2016-12-31
2016-11-04 3858.57 未披露 定期报告 2016-10-28
2016-11-04 3858.28 未披露 定期报告 2016-09-30
2016-08-09 3850.11 未披露 定期报告 2016-07-29
2016-08-09 3850.06 未披露 定期报告 2016-06-30
2016-06-10 3838.57 未披露 定期报告 2016-04-29
2016-04-27 3838.57 未披露 定期报告 2016-04-11
2016-05-09 3836.45 未披露 定期报告 2016-03-31
2016-02-29 3835.95 未披露
更多>>
from December 31, 2014 to December 31, 2015 Issuance of common stock, net of issuance costs of $17,741 Issuance of common stock under employee stock purchase plan Exercise of stock options
2015-12-31
2015-11-06 3832.06 未披露 定期报告 2015-10-30
2015-11-06 3828.10 未披露 定期报告 2015-09-30
2015-08-07 3820.65 未披露
更多>>
In July 2015, the Company sold 4,054,487 shares of its common stock in a public offering at $78.00 per share.
2015-07-31
2015-08-07 3414.71 未披露 定期报告 2015-06-30
2015-05-08 3406.48 未披露 定期报告 2015-05-01
2015-04-30 3406.27 未披露 定期报告 2015-04-13
2015-05-08 3406.26 未披露 定期报告 2015-03-31
2015-02-27 3401.79 未披露 定期报告 2015-02-20
2015-02-27 3397.72 未披露
更多>>
from December 31,2013 to December 31,2014 Issuance of common stock under employee stock purchase plan Exercise of stock options
2014-12-31
2014-11-07 3396.44 未披露 定期报告 2014-10-31
2014-11-07 3396.41 未披露 定期报告 2014-09-30
2014-08-08 3396.40 未披露 定期报告 2014-06-30
2014-05-09 3391.16 未披露 定期报告 2014-05-01
2014-05-09 3390.16 未披露 定期报告 2014-03-31
2014-02-28 3389.96 未披露 定期报告 2014-02-24
2014-02-28 3389.73 未披露
更多>>
from December 31,2012 to December 31,2013 Issuance of common stock, net of issuance costs of $15,929 Issuance of common stock related to EOS acquisition Issuance of common stock under employee stock purchase plan Exercise of stock options
2013-12-31
2013-11-07 3017.14 未披露 定期报告 2013-09-30
2013-08-07 3017.14 未披露 定期报告 2013-08-01
2013-08-07 3016.98 未披露 定期报告 2013-06-30
2013-05-08 2626.51 未披露 定期报告 2013-05-02
2013-04-29 2626.27 未披露 定期报告 2013-04-15
2013-05-08 2621.86 未披露 定期报告 2013-03-31
2013-03-14 2621.55 未披露 定期报告 2013-03-11
2013-03-14 2620.72 未披露
更多>>
from December 31, 2011 to December 31, 2012 Issuance of common stock, net of issuance costs of $5,024 Issuance of common stock under employee stock purchase plan Exercise of stock options
2012-12-31
2012-08-10 2613.93 未披露 定期报告 2012-06-30
2012-05-11 2237.90 未披露 定期报告 2012-03-31
2012-03-15 2237.58 未披露
更多>>
from Dec 31,2010 to Dec 31,2011 Issuance of common stock, net of issuance costs of $9,745 Exercise of stock options Conversion of convertible promissory notes and accrued interest into common stock Conversion of convertible preferred stock into common stock
2011-12-31
From June 30, 2022 to September 30, 2022 Issuance of common stock from vesting of restricted stock units
From March 31, 2022 to June 30, 2022 Issuance of common stock from vesting of restricted stock units Issuance of common stock under employee stock purchase plan
From January 1, 2022 to March 31, 2022 Issuance of common stock, net of issuance costs Issuance of common stock from vesting of restricted stock units
From December 31, 2020 to December 31, 2021 Issuance of common stock, net of issuance costs Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units
from June 30, 2021 to September 30, 2021 Issuance of common stock from vesting of restricted stock units Issuance of common stock, net of issuance costs
From March 31, 2021 to June 30, 2021 Exercise of stock options Issuance of common stock from vesting of restricted stock units Issuance of common stock under employee stock purchase plan Issuance of common stock, net of issuance costs
from January 1, 2021 to March 31, 2021 Exercise of stock options Issuance of common stock from vesting of restricted stock units
From December 31, 2019 to December 31, 2020 Issuance of common stock, net of issuance costs Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units Convertible senior notes conversion
From June 30, 2020 to September 30, 2020 Issuance of common stock from vesting of restricted stock units
From March 31, 2020 to June 30, 2020 Exercise of stock options Issuance of common stock from vesting of restricted stock units Issuance of common stock under employee stock purchase plan Issuance of common stock, net of issuance costs Convertible senior notes conversion
Clovis Oncology, Inc. (NASDAQ:CLVS) announced today the pricing of 11,090,000 shares of its common stock in an underwritten public offering at a price to the public of $8.05 per share, before underwriting discounts and commissions. Clovis Oncology also granted to the underwriters a 30-day option to purchase up to an additional 1,663,500 shares of its common stock on the same terms and conditions. The offering is expected to close on May 21, 2020.
From January 1, 2020 to March 31, 2020 Exercise of stock options Issuance of common stock from vesting of restricted stock units Convertible senior notes conversion
From December 31, 2018 to December 31, 2019 Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units Legal settlement
From June 30, 2019 to September 30, 2019 Litigation settlement Exercise of stock options Issuance of common stock from vesting of restricted stock units
from March 31, 2019 to June 30,2019 Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units
from January 1, 2019 to March 31, 2019 Exercise of stock options Issuance of common stock from vesting of restricted stock units, net of shares withheld for taxes
from December 31, 2017 to December 31, 2018 Issuance of common stock, net of issuance costs Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units, net of shares withheld for taxes
from December 31, 2016 to December 31, 2017 Issuance of common stock, net of issuance costs Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units, net of shares withheld for taxes Legal settlement
from December 31, 2015 to December 31, 2016 Issuance of common stock under employee stock purchase plan Exercise of stock options Issuance of common stock from vesting of restricted stock units, net of shares withheld for taxes
from December 31, 2014 to December 31, 2015 Issuance of common stock, net of issuance costs of $17,741 Issuance of common stock under employee stock purchase plan Exercise of stock options
In July 2015, the Company sold 4,054,487 shares of its common stock in a public offering at $78.00 per share.
from December 31,2013 to December 31,2014 Issuance of common stock under employee stock purchase plan Exercise of stock options
from December 31,2012 to December 31,2013 Issuance of common stock, net of issuance costs of $15,929 Issuance of common stock related to EOS acquisition Issuance of common stock under employee stock purchase plan Exercise of stock options
from December 31, 2011 to December 31, 2012 Issuance of common stock, net of issuance costs of $5,024 Issuance of common stock under employee stock purchase plan Exercise of stock options
from Dec 31,2010 to Dec 31,2011 Issuance of common stock, net of issuance costs of $9,745 Exercise of stock options Conversion of convertible promissory notes and accrued interest into common stock Conversion of convertible preferred stock into common stock